Prevention · 4 min
Genes load the gun, lifestyle pulls the trigger
Genetic testing has moved from the lab to the inbox. The question is no longer whether you can sequence your DNA — it is which of the results actually change what you should do on Monday morning.
What is genuinely actionable
A small set of variants change clinical decisions today. APOE genotype meaningfully influences Alzheimer's risk and lipid response (an APOE4 carrier benefits even more from controlling ApoB and blood pressure early). Familial hypercholesterolaemia variants warrant aggressive lifid management from young adulthood. BRCA and Lynch syndrome variants change cancer screening. Pharmacogenomic variants (e.g. CYP2C19) influence drug choice.
What is overstated
Most direct-to-consumer 'nutrigenetic' panels report variants — like MTHFR or FTO — whose individual effects on metabolism are small and easily overwhelmed by sleep, exercise and diet. A high polygenic risk score for coronary disease is meaningful, but the same lifestyle factors that protect everyone else protect you proportionally more, not less.
The interaction is the point
Large studies consistently show that adherence to a healthy lifestyle attenuates genetic risk substantially — roughly halving the lifetime risk of coronary disease in those with high polygenic risk. Genes are real. They are not destiny.
What to do this week
- Know your family history in detail — it is still the most useful 'genetic test' available.
- Consider clinically validated testing (APOE, Lp(a), familial hypercholesterolaemia panel) if family history warrants.
- Treat consumer nutrigenetic reports as hypotheses, not prescriptions.
- Whatever your genotype: sleep, train, eat well, manage ApoB and blood pressure.